Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Phase III results reported for Prosorba

Jan. 30, 1998

ADIR prepares MMP inhibitors for arthritis, cancer, atherosclerosis

Jan. 27, 1998

Boston Life Sciences to seek U.S. approval for Therafectin

Jan. 23, 1998

Inhibitors of prostaglandin biosynthesis prepared at Abbott

Jan. 23, 1998

Connetics amends payment terms, sells Canadian rights to Ridaura

Jan. 22, 1998

Inhibitors of COX-1/COX-2 from Roche

Jan. 22, 1998

Hydroxamic acid-based inhibitors of TNF and/or MMPs under study at Zeneca

Jan. 22, 1998

Innovative Therapies for Rheumatoid Arthritis

Jan. 22, 1998

Preclinical efficacy results reported for Maruho's NSAID

Jan. 20, 1998

Thienopyridine derivatives for arthritis, osteoporosis from Takeda

Jan. 19, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...